Summary
In 49 patients treated with intravenous phenytoin after a neurosurgical procedure or because of repetitive frequent seizures, the serum concentration was measured before and 2 hours after an intravenous bolus injection. Based on these data the apparent volume of distribution and intra- and interpatient variability were determined in this representative patient population, using the statistical package NONMEM. From 5 characteristics tested (age, sex, bodyweight, serum albumin, renal function) only bodyweight was found to significantly influence the apparent volume of distribution of phenytoin. The population average was estimated as 1.0 ± 0.04 L/kg (estimate ± SE) and interindividual variability, expressed as coefficient of variation, was 23 ± 6%. By means of Monte Carlo simulations an optimal dosing scheme for phenytoin loading has been calculated. Based on these results, a dose of 15 mg/kg divided into 3 intravenous injections administered 2 hours apart at a maximum rate of 50 mg/min is recommended. This loading regimen should result in therapeutic concentrations (10 to 20 mg/L) in 90% of patients within 6 hours.
Similar content being viewed by others
References
Abernethy DR, Greenblatt DJ. Phenytoin disposition in obesity: determination of loading dose. Archives of Neurology 42: 468–71, 1985
Bard Y. Nonlinear parameter estimation, p. 74, Academic Press, New York, 1974
Bard Y. Nonlinear parameter estimation, pp. 204–205, Academic Press, New York, 1974a
Beal SL, Sheiner LB. The NONMEM system. American Statistician 34: 118–119, 1980
Beal SL, Sheiner LB. NONMEM users guide, parts I, II, V, and VI. Technical Report of the Division of Clinical Pharmacology, University of California at San Francisco, 1985
Cranford RE, Leppik IE, Patrick B, Anderson CB, Kostick B. Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology 28: 874–880, 1978
Earnest MP, Marx JA, Drury LR. Complications of intravenous phenytoin for acute treatment of seizures: recommendations for usage. Journal of the American Medical Association 249: 762–765, 1983
Grasela TH, Sheiner LB, Rambeck B, Boenigk HE, Dunlop A, et al. Steady-state pharmacokinetics of phenytoin from routinely collected patient data. Clinical Pharmacokinetics 8: 355–364, 1983
Ludden TM, Allen JP, Valutzky WA, Vicuna AV, Nappi JM, et al. Individualization of phenytoin dosage regimens. Clinical Pharmacology and Therapeutics 21: 287–293, 1977
Martin E, Tozer TN, Sheiner LB, Riegelman S. The clinical pharmacokinetics of phenytoin. Journal of Pharmacokinetics and Biopharmaceutics 5: 579–595, 1977
North JB, Hanieh A, Challen RG, Penhall RK, Hann CS, et al. Postoperative epilepsy: a double-blind trial of phenytoin after craniotomy. Lancet 1: 384–386, 1980
North JB, Penhall RK, Hanieh A, Frewin DB, Taylor WB. Phenytoin and postoperative epilepsy: a double-blind study. Journal of Neurosurgery 58: 672–677, 1983
Rall TW, Schleifer LS. Drugs effective in the therapy of epilepsies. In Gilman et al. (Eds) The pharmacological basis of therapeutics, pp. 446–472, Macmillan Publishing Company, New York 1985
Richens A, Dunlop A. Serum-phenytoin levels in management of epilepsy. Lancet 2: 247–248, 1975
Salem RB, Wilder BJ, Yost RL, Doering PL, Lee C. Rapid infusion of phenytoin sodium loading doses. American Journal of Hospital Pharmacology 38: 354–357, 1981
Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. Journal of Pharmacokinetics and Biopharmaceutics 5: 445–479, 1977
Stilman N, Masdeu JC. Incidence of seizures with phenytoin toxicity. Neurology 35: 1769–1772, 1985
Treiman DM. General principles of treatment: responsive and intractable status epilepticus in adults. In Delagado-Escueta et al. (Eds) Advances in neurology, vol. 34: Status epilepticus, pp. 377–384, Raven Press, New York, 1983
Turnbull DM, Howel D, Rawlins MD, Chadwick DW. Which drug for the adult epileptic patient: phenytoin or valproate? British Medical Journal 290: 815–819, 1985
Vozeh S, Follath F. Nomographic estimation of time to reach steady-state serum concentration during phenytoin therapy. European Journal of Clinical Pharmacology 17: 33–35, 1980
Vozeh S, Muir KT, Follath F, Sheiner LB. Predicting individual phenytoin dosage. Journal of Pharmacokinetics and Biopharmaceutics 9: 131–145, 1981
Vozeh S, Uematsu T, Hauf GF, Follath F. Performance of Bayesian feedback to forecast lidocaine serum concentration: evaluation of the prediction error and the prediction interval. Journal of Pharmacokinetics and Biopharmaceutics 13: 203–212, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vožeh, S., Uematsu, T., Aarons, L. et al. Intravenous Phenytoin Loading in Patients after Neurosurgery and in Status Epilepticus. Clin-Pharmacokinet 14, 122–128 (1988). https://doi.org/10.2165/00003088-198814020-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198814020-00004